***Background.*** Interferon-γ release assays (IGRAs) are blood-based tests used to screen millions of U.S. health care workers for latent tuberculosis infection but recent studies indicate they lack specificity. Skin microbiota and microbe-associated molecular patterns (MAMPs) are known contaminants of blood draws, but their immunomodulatory impact on IGRAs has not been evaluated.

***Objectives.*** To investigate the effects of microbial contaminants and MAMPs on the accuracy of QuantiFERON-TB Gold In-Tube assay (Qiagen, Carnegie, Australia).

***Methods.*** We performed the QuantiFERON-TB Gold In-Tube assay in uninfected and infected volunteers with and without bacteria and MAMPs added to the Nil tube and the TB antigen tube. Outcome measures were quantitative results and proportions of false positive results.

***Results.*** As few as 10 colony forming units of *Staphylococcus aureus*, a skin colonizer, was sufficient to cause false positives in 6.9% (P \< 0.008) of 58 uninfected volunteers. *Escherichia coli*, an environmental contaminant, caused false positive results at a higher inoculum. Survival and replication of *S. aureus* in blood was essential for its potent immunomodulatory effect. Lipopolysaccharide, a MAMP common to gut microbes, at 10 ng/ml caused false positives in 23.5% (P \< 0.001) of 17 volunteers.

***Conclusion.*** Skin microbiota cause false positive IGRA results. Standardized disinfection of skin and blood collection tubes is essential but not sufficient for eliminating false positive results due to skin contaminants.

***Disclosures.*** **All authors:** No reported disclosures.

[^1]: **Session:** 174. Clinical Infectious Diseases

[^2]: Saturday, October 11, 2014: 8:30 AM
